Efficacy and safety of octreotide versus somatostatin therapy after CRS + HIPEC in patients with peritoneal carcinomatosis

Abstract Objectives This study aimed to compare the efficacy and safety of perioperative somatostatin versus octreotide in peritoneal carcinomatosis (PC) patients after cytoreductive surgery (CRS) + hyperthermic intraperitoneal chemotherapy (HIPEC). Methods Peritoneal cancer patients treated with CR...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Bing Li, Zhong-He Ji, Gang Liu, Yang Yu, Yan Li
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Springer 2026-01-01
Ráidu:	Discover Oncology
Fáttát:	Peritoneal carcinoma Cytoreductive surgery Hyperthermic intraperitoneal chemotherapy Serious adverse events Octreotide Somatostatin
Liŋkkat:	https://doi.org/10.1007/s12672-026-04420-7
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!